View in EDS

Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis.

Saved in:
Bibliographic Details
Title: Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis.
Authors: Jung HR; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea., Lee J; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea., Hong SP; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea., Shin N; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea., Cho A; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea., Shin DJ; Medicine Major, Seoul National University College of Medicine, Seoul, Republic of Korea., Choi JW; College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea., Kim JI; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea., Lee JP; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. nephrolee@gmail.com.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea. nephrolee@gmail.com., Cho SY; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea. csybio@snu.ac.kr.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea. csybio@snu.ac.kr.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea. csybio@snu.ac.kr.
Source: Experimental & molecular medicine [Exp Mol Med] 2024 Feb; Vol. 56 (2), pp. 355-369. Date of Electronic Publication: 2024 Feb 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9607880 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2092-6413 (Electronic) Linking ISSN: 12263613 NLM ISO Abbreviation: Exp Mol Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2092-6413
DOI:10.1038/s12276-024-01159-5